Biotech Values

[DewDiligence]

ACIP endorses Prevnar-20 for infants/children:

https://www.pfizer.com/news/announcements/advisory-committee-immunization-practices-recommends-prevnar-20r-20-valent

The recommendation is: a primary 4-shot regimen with doses at 2, 4, 6, and 12-15 months; and a “catch-up” dose for healthy children age 2-5 years who did not complete the full primary series.